This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 27/10/2198    most recent ATVBAHA.107.148429v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhou, Y. Articles by Liu, J. Search for Related Content PubMed PubMed Citation Articles by Zhou, Y. Articles by Liu, J. Pubmed/NCBI databases Gene GEO Profiles HomoloGene Protein UniGene Compound via MeSH Substance via MeSH Medline Plus Health Information Triglycerides

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:2198.)
© 2007 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

Transcriptional Activation of Hepatic ACSL3 and ACSL5 by Oncostatin M Reduces Hypertriglyceridemia Through Enhanced β-Oxidation

Yue Zhou; Parveen Abidi; Aekyong Kim; Wei Chen; Ting-Ting Huang; Fredric B. Kraemer; Jingwen Liu

From the VA Palo Alto Health Care System, Palo Alto, Calif.

Correspondence to Jingwen Liu, PhD (154P), VA Palo Alto Health Care System, 3801 Miranda Avenue, Palo Alto, CA 94304. E-mail Jingwen. Liu{at}med.va.gov

Objective— In our previous studies that examined in vivo activities of oncostatin M (OM) in upregulation of hepatic LDL receptor (LDLR) expression, we observed reductions of LDL-cholesterol and triglyceride (TG) levels in OM-treated hyperlipidemic hamsters. Interestingly, the OM effect of lowering plasma TG was more pronounced than LDL-cholesterol reduction, suggesting additional LDLR-independent actions. Here, we investigated mechanisms underlying the direct TG-lowering effect of OM.

Methods and Results— We demonstrate that OM activates transcription of long-chain acyl-coenzymeA (CoA) synthetase isoforms 3 and 5 (ACSL3, ACSL5) in HepG2 cells through the extracellular signal-regulated kinase (ERK) signaling pathway. Increased acyl-CoA synthetase activities in OM-stimulated HepG2 cells and in livers of OM-treated hamsters are associated with decreased TG accumulation and increased fatty acid β-oxidation. We further show that overexpression of ACSL3 or ACSL5 alone in the absence of OM led to fatty acid partitioning into β-oxidation. Importantly, we demonstrate that transfection of siRNAs targeted to ACSL3 and ACSL5 abrogated the enhancing effect of OM on fatty acid oxidation in HepG2 cells.

Conclusions— These new findings identify ACSL3 and ACSL5 as OM-regulated genes that function in fatty acid metabolism and suggest a novel cellular mechanism by which OM directly lowers the plasma TG in hyperlipidemic animals through stimulating the transcription of ACSL specific isoforms in the liver.

In this study we investigated the mechanisms underlying the direct TG-lowering effects of OM in hyperlipidemic hamsters and in HepG2 cells. We demonstrate that OM activates ACSL3/5 transcription through the ERK signaling pathway. The increased ACSL3/5 enzymatic activities in liver cells stimulate fatty acid partition toward β-oxidation with a fall in TG synthesis.

Key Words: Acyl-CoA synthetase • oncostatin M • hypertriglyceridemia • ERK • fatty acid β-oxidation

This article has been cited by other articles:

				A. C. T. Teng, K. Adamo, F. Tesson, and A. F. R. Stewart Functional characterization of a promoter polymorphism that drives ACSL5 gene expression in skeletal muscle and associates with diet-induced weight loss FASEB J, June 1, 2009; 23(6): 1705 - 1709. [Abstract] [Full Text] [PDF]